View All Reports Email Us

Global Cancer Biologic Therapy Market Research Report - Forecast to 2021 Global Cancer Biologic Therapy Market Research Report - Forecast to 2021

  • ID: MRFR/HC/0123-HCRR
  • |
  • April, 2017
  • |
  • Region: Global
  • |
  • 115 pages
  • |
  • Half-Cooked Research Reports

Global Cancer Biologic Therapy Market– Forecast to 2021 The report firstly introduced Global Cancer Biologic Therapy Market including classification, application and industry chain overview; Then we deeply analyzed global growth forecast indicators by the as well as the regional market conditions that including the product price, profit, utilization, supply, demand and industry growth rate etc.

In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Global Cancer Biologic Therapy Market.

We are thankful for the support and assistance from Global Cancer Biologic Therapy Market. industry chain related technical experts and marketing experts during Research Team survey and interviews.

Table of Contents

1 Introduction

1.1 Definition

1.2 Scope of the study

1.2.1 Research Objectives

1.2.2 Assumptions & Limitations

1.3 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

2.4 Forecast Model

3 Report Excerpt

4 Forecast Indicators

4.1 Introduction

4.2 Growth Drivers

4.2.1 Increasing Incidences of Cancer

4.2.2 Benefit of Immunotherapy Over Other Treatments

4.2.3 Fast Track and Orphan Drug Designations

4.3 Growth Barriers

4.3.1 High Cost of Immunotherapy Treatment

4.5 Macroecnomical Indicators

5 Market Analysis (Any 2)

5.1 Porter's Five Force

5.2 Regulatory Framework

6 Pipeline Analysis, by Phases

6.1 Phase 1

6.2 Phase I/II

6.3 Phase II

6.4 Phase II/III

6.5 Phase III

6.6 Application Submitted

7 Global Cancer Biologic Therapy Market, by Type

7.1 Monoclonal Antibodies

7.1.1 Naked monoclonal Antibodies

7.1.2 Conjugated Monoclonal Antibodies

7.1.3 Bispecific monoclonal antibodies

7.2 Immuno Checkpoints Inhibitors

7.2.1 PD-1/PD-L1

7.2.2 CTLA-4 7.3 Cancer Vaccine

7.3.1 Sipuleucel-T

7.3.2 Others

7.4 Non-Specific Cancer Immunotherapies and Adjuvants Cytokines Interleukins Interferons

7.5 Others

8 Global Cancer Biologic Therapy Market, by Region

8.1 North America

8.1.1 USA

8.1.2 Canada

8.2 Europe

8.2.1 Germany

8.2.2 France

8.2.3 U.K.

8.2.4 Rest of Europe

8.3 Asia

8.3.1 India

8.3.2 China

8.3.3 Japan

8.3.4 Rest of Asia

8.4 Rest of the World

9 Competitive Landscape

9.1 Market Share Analysis

9.2 Competitive/Strategic Scenario

9.2.1 Mergers Acquisitions

9.2.2 Collaborations

9.2.3 Expansion

9.2.4 New Product Launches

10 Company Profiles

10.1 F. Hoffmann-La Roche Ag

10.2 Merck & Co., Inc.

10.3 Novartis International Ag

10.4 Glaxosmithkline Plc

10.5 Amgen Inc.

10.6 Bristol-Myers Squibb

10.7 ELI Lilly and Company

10.8 Celgene Corporation

10.9 Seattle Genetics, Inc.

10.10 Spectrum Pharmaceuticals, Inc.

captcha
Please enter code
captcha
Please enter code

Purchase this Market Research Report

Add To Cart

Market Research Videos

Related TAGS

Related Report

Related Categories

REPORT YOU MIGHT BE INTERESTED

Contact Us

Email Us at: salesteam@marketresearchfuture.com | Reach Us at: + (646) 845 9349 (US), +44 208 133 9349 (uk)